{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:02:18Z","timestamp":1740157338101,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Amryt Pharmaceuticals, DAC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s40271-021-00511-5","type":"journal-article","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T02:02:15Z","timestamp":1618106535000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Experiences and Perspectives of Patients with Non-HIV-Associated Lipodystrophies and Their Caregivers: A Qualitative Study"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-8201","authenticated-orcid":false,"given":"Aparna","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keziah","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,11]]},"reference":[{"issue":"11","key":"511_CR1","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96(11):3313\u201325. https:\/\/doi.org\/10.1210\/jc.2011-1159.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"511_CR2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220\u201334. https:\/\/doi.org\/10.1056\/NEJMra025261.","journal-title":"N Engl J Med."},{"key":"511_CR3","unstructured":"National Organization for Rare Disorders (NORD). The physician\u2019s guide to lipodystrophy disorders. 2014. https:\/\/rarediseases.org\/physician-guide\/lipodystrophy-disorders\/. Accessed 9 May 2018."},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/tcrm.s66521","volume":"11","author":"AJ Rodriguez","year":"2015","unstructured":"Rodriguez AJ, Mastronardi CA, Paz-Filho GJ. New advances in the treatment of generalized lipodystrophy: role of metreleptin. Ther Clin Risk Manage. 2015;11:1391\u2013400. https:\/\/doi.org\/10.2147\/tcrm.s66521.","journal-title":"Ther Clin Risk Manage."},{"issue":"7","key":"511_CR5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2337\/diabetes.54.7.1994","volume":"54","author":"ED Javor","year":"2005","unstructured":"Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. 2005;54(7):1994\u20132002.","journal-title":"Diabetes"},{"issue":"8","key":"511_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570\u20138. https:\/\/doi.org\/10.1056\/NEJMoa012437.","journal-title":"N Engl J Med."},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/dmso.S130810","volume":"10","author":"E Chiquette","year":"2017","unstructured":"Chiquette E, Oral EA, Garg A, Ara\u00fajo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017;10:375\u201383. https:\/\/doi.org\/10.2147\/dmso.S130810.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"2\u20133","key":"511_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.healthpol.2012.02.018","volume":"105","author":"K Budych","year":"2012","unstructured":"Budych K, Helms TM, Schultz C. How do patients with rare diseases experience the medical encounter? Exploring role behavior and its impact on patient-physician interaction. Health Policy. 2012;105(2\u20133):154\u201364. https:\/\/doi.org\/10.1016\/j.healthpol.2012.02.018.","journal-title":"Health Policy"},{"key":"511_CR9","volume-title":"Juggling care and daily life: the balancing act of the rare disease community. A rare barometer survey","author":"EURODIS-Rare Disease Europe","year":"2017","unstructured":"EURODIS-Rare Disease Europe. Juggling care and daily life: the balancing act of the rare disease community. A rare barometer survey. Paris: EURODIS-Rare Disease Europe; 2017."},{"issue":"10","key":"511_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ejhg.2013.15","volume":"21","author":"V Eatough","year":"2013","unstructured":"Eatough V, Santini H, Eiser C, Goller M-L, Krysa W, Paduanello M, et al. The personal experience of parenting a child with juvenile Huntington\u2019s disease: perceptions across Europe. Eur J Hum Genet. 2013;21(10):1042.","journal-title":"Eur J Hum Genet."},{"issue":"2","key":"511_CR11","first-page":"189","volume":"18","author":"E Strehle","year":"2007","unstructured":"Strehle E, Middlemiss P. Children with 4q-syndrome: the parents\u2019 perspective. Genet Couns. 2007;18(2):189\u2013200.","journal-title":"Genet Couns."},{"issue":"1","key":"511_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1552-6909.12268","volume":"43","author":"MT Rivard","year":"2014","unstructured":"Rivard MT, Mastel-Smith B. The lived experience of fathers whose children are diagnosed with a genetic disorder. J Obstet Gynecol Neonatal Nurs. 2014;43(1):38\u201349.","journal-title":"J Obstet Gynecol Neonatal Nurs."},{"issue":"9629","key":"511_CR13","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/s0140-6736(08)60872-7","volume":"371","author":"A Schieppati","year":"2008","unstructured":"Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371(9629):2039\u201341. https:\/\/doi.org\/10.1016\/s0140-6736(08)60872-7.","journal-title":"Lancet"},{"key":"511_CR14","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-MON-101","author":"A Jalal Eldin","year":"2019","unstructured":"Jalal Eldin A, Akinci B, Meral R, Rus D, Swaidan M, Hench R, et al. MON-101 The LD Lync Study: natural history study of lipodystrophy syndromes: early lessons from the pilot data. J Endocrine Soc. 2019. https:\/\/doi.org\/10.1210\/js.2019-MON-101.","journal-title":"J Endocrine Soc."},{"key":"511_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab019","author":"K Cook","year":"2021","unstructured":"Cook K, Adamski K, Gomes A, Tuttle E, Kalden H, Cochran E, et al. Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy. J Endocrine Soc. 2021. https:\/\/doi.org\/10.1210\/jendso\/bvab019.","journal-title":"J Endocrine Soc."},{"issue":"9","key":"511_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"H-F Hsieh","year":"2005","unstructured":"Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res."},{"issue":"1","key":"511_CR17","doi-asserted-by":"publisher","first-page":"215824401452263","DOI":"10.1177\/2158244014522633","volume":"4","author":"S Elo","year":"2014","unstructured":"Elo S, K\u00e4\u00e4ri\u00e4inen M, Kanste O, P\u00f6lkki T, Utriainen K, Kyng\u00e4s H. Qualitative content analysis: a focus on trustworthiness. SAGE Open. 2014;4(1):2158244014522633.","journal-title":"SAGE Open"},{"issue":"6","key":"511_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care."},{"issue":"6","key":"511_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/mgg3.315","volume":"5","author":"C von der Lippe","year":"2017","unstructured":"von der Lippe C, Diesen PS, Feragen KB. Living with a rare disorder: a systematic review of the qualitative literature. Mol Gen Genom Med. 2017;5(6):758\u201373. https:\/\/doi.org\/10.1002\/mgg3.315.","journal-title":"Mol Gen Genom Med."},{"key":"511_CR20","doi-asserted-by":"crossref","unstructured":"Cook K, Stears A, Araujo-Vilar D, Santini F, O\u2019Rahilly S, Ceccarini G, et al. Real-world experience of patients with generalized and partial lipodystrophy enrolled in the metreleptin early access program. In: 21st European Congress of Endocrinology; 18\u201321 May 2019; Lyon.","DOI":"10.1530\/endoabs.63.P586"},{"issue":"11","key":"511_CR21","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1210\/jc.2018-02730","volume":"104","author":"B Akinci","year":"2019","unstructured":"Akinci B, Oral EA, Neidert A, Rus D, Cheng WY, Thompson-Leduc P, et al. Comorbidities and survival in patients with lipodystrophy: an international chart review study. J Clin Endocrinol Metab. 2019;104(11):5120\u201335. https:\/\/doi.org\/10.1210\/jc.2018-02730.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"511_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.29119","volume":"121","author":"EE Kent","year":"2015","unstructured":"Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD. Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer. 2015;121(5):758\u201365.","journal-title":"Cancer"},{"issue":"11","key":"511_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41419-018-1129-1","volume":"9","author":"T Ge","year":"2018","unstructured":"Ge T, Fan J, Yang W, Cui R, Li B. Leptin in depression: a potential therapeutic target. Cell Death Dis. 2018;9(11):1096. https:\/\/doi.org\/10.1038\/s41419-018-1129-1.","journal-title":"Cell Death Dis."},{"issue":"1","key":"511_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40271-014-0085-9","volume":"8","author":"M Doyle","year":"2015","unstructured":"Doyle M. Peer support and mentorship in a US rare disease community: findings from the Cystinosis in Emerging Adulthood Study. Patient. 2015;8(1):65\u201373. https:\/\/doi.org\/10.1007\/s40271-014-0085-9.","journal-title":"Patient."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00511-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-021-00511-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00511-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:59:15Z","timestamp":1671843555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-021-00511-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s40271-021-00511-5","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"type":"print","value":"1178-1653"},{"type":"electronic","value":"1178-1661"}],"subject":[],"published":{"date-parts":[[2021,4,11]]},"assertion":[{"value":"14 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Aegerion Pharmaceuticals Inc. (a wholly owned subsidiary of Amryt Pharmaceuticals) and Amryt Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Aparna Gomes, Keziah Cook, Alex Wong, and Edward Tuttle are employees of Analysis Group, Inc., which has received consultancy fees. Rebecca Sanders is the Co-Founder and Chair of Lipodystrophy UK. Andra Stratton is the Co-Founder and President of Lipodystrophy United.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"The New England Independent Review Board reviewed the study protocol and discussion guide prior to granting an exemption from formal institutional review board review and approval as this study only involves the use of educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, and interview procedures and information was not recorded in such a manner that human subjects can be identified. UK National Health Service Research Ethics Committee approval was not required for participants located in England.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Verbal informed consent was obtained from all individual participants included in the study prior to the interviews.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Verbal informed consent was obtained from all individual participants to publish non-identifying information collected during the interview.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable as no datasets were generated or analyzed during the current study. Interview transcripts are not publicly available and will not be shared by the corresponding author to protect participant identities.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The codebook generated during this study is available from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AG, KC, and ET contributed to the study conception and design. ET contributed to material preparation and data collection. RS contributed to reviewing the interview questions during the design phase and recruiting participants from the patient community. Data analysis were performed by AG, KC, and AW. The first draft of the manuscript was written by AG, KC, AW, and ET and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}